Loading

ABT — ABBOTT LABORATORIES · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

ABT

ABBOTT LABORATORIESD4615-min delayed · EOD close

108.79▼ −1.52% downas of 2026-09-03mkt cap $189B

Pharmaceutical Preparations · SIC 2834 · CIK 0000001800

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Market cap

$189B

P/E

30.2

Net margin

13.9%

ROE

12.1%

Revenue

$45.1B

latest annual

Net income

$6.3B

latest annual

Shares out

1.7B

Free cash flow

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

$7.4B

52-week range

Current: 108.79

▲

Low

100.75

High

116.67

Quality score

46/100

D

Growth18

Business quality46

missing: grossMargin

Financial healthno data

missing: debtToEquity, cashToLiabilities

Valuation74

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.